The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423] ; volume:6 ; number:1 ; day:11 ; month:10 ; year:2005 ; pages:1-9 ; date:12.2005
Trials ; 6, Heft 1 (11.10.2005), 1-9, 12.2005
- Urheber
-
Kulik, Alexander
- Beteiligte Personen und Organisationen
-
Le May, Michel
Wells, George A.
Mesana, Thierry G.
Ruel, Marc
SpringerLink (Online service)
- DOI
-
10.1186/1468-6708-6-15
- URN
-
urn:nbn:de:1111-2016050215676
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kulik, Alexander
- Le May, Michel
- Wells, George A.
- Mesana, Thierry G.
- Ruel, Marc
- SpringerLink (Online service)
Ähnliche Objekte (12)
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]
Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]
Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]
Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis